New vaccine on the cards for South Africa

• A new vaccine for tuberculosis (TB) is being developed and could potentially help eliminate TB as a public health threat by 2030.
• The M72/ASO1E vaccine is currently in phase 3 trials in South Africa, Kenya, Zambia, Malawi, and Indonesia, and has shown promise in previous trials.
• If approved, the vaccine will be the first TB vaccine introduced in over a century, and its introduction is expected to boost South Africa's economic growth and support the country's efforts to tackle TB.